Medtronic, Inc. Stock Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 17 | Medtronic Trial for AFib System Achieves Endpoints | DJ |
May. 17 | Medtronic Says Small-Diameter Defibrillation Lead Meets Safety, Efficacy Goals in Pivotal Trial | MT |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.57B | Capitalization | 114B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 4.23 x |
Net Debt 2024 * | 22.21B | Net Debt 2025 * | 21.12B | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
21.2
x | Employees | - |
Yield 2024 * |
3.2% | Yield 2025 * |
3.37% | Free-Float | 99.78% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 63 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-5.43% | 182B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B | |
-1.25% | 24.94B |